Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 7.32 Billion DKK | 8.11% |
| 2023 | 6.77 Billion DKK | 5.16% |
| 2022 | 6.43 Billion DKK | 1.32% |
| 2021 | 6.35 Billion DKK | 8.56% |
| 2020 | 5.85 Billion DKK | 13.54% |
| 2019 | 5.15 Billion DKK | 1.28% |
| 2018 | 5.09 Billion DKK | 1.33% |
| 2017 | 5.02 Billion DKK | 22.66% |
| 2016 | 4.09 Billion DKK | 166.84% |
| 2015 | 1.53 Billion DKK | -51.22% |
| 2014 | 3.14 Billion DKK | -14.3% |
| 2013 | 3.67 Billion DKK | 12.81% |
| 2012 | 3.25 Billion DKK | 26.11% |
| 2011 | 2.58 Billion DKK | 29.37% |
| 2010 | 1.99 Billion DKK | 43.01% |
| 2009 | 1.39 Billion DKK | 40.34% |
| 2008 | 994 Million DKK | 32.71% |
| 2007 | 749 Million DKK | -14.79% |
| 2006 | 879 Million DKK | -12.1% |
| 2005 | 1 Billion DKK | 0.28% |
| 2004 | 997.17 Million DKK | 7.11% |
| 2003 | 931 Million DKK | 1.42% |
| 2002 | 918 Million DKK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.82 Billion DKK | 10.76% |
| 2024 Q3 | 1.85 Billion DKK | 3.03% |
| 2024 Q2 | 1.78 Billion DKK | -2.31% |
| 2023 FY | 6.77 Billion DKK | 5.16% |
| 2023 Q2 | 1.65 Billion DKK | -6.25% |
| 2023 Q1 | 1.76 Billion DKK | -0.96% |
| 2023 Q4 | 1.64 Billion DKK | -4.03% |
| 2023 Q3 | 1.71 Billion DKK | 3.82% |
| 2022 Q1 | 1.61 Billion DKK | -12.7% |
| 2022 FY | 6.43 Billion DKK | 1.32% |
| 2022 Q4 | 1.77 Billion DKK | 2.13% |
| 2022 Q3 | 1.74 Billion DKK | 33.41% |
| 2022 Q2 | 1.3 Billion DKK | -19.2% |
| 2021 FY | 6.35 Billion DKK | 8.56% |
| 2021 Q1 | 1.53 Billion DKK | 4.35% |
| 2021 Q2 | 1.37 Billion DKK | -10.35% |
| 2021 Q3 | 1.59 Billion DKK | 15.61% |
| 2021 Q4 | 1.85 Billion DKK | 16.21% |
| 2020 Q4 | 1.47 Billion DKK | 7.6% |
| 2020 Q3 | 1.36 Billion DKK | -11.28% |
| 2020 Q1 | 1.47 Billion DKK | 36.42% |
| 2020 FY | 5.85 Billion DKK | 13.54% |
| 2020 Q2 | 1.54 Billion DKK | 4.76% |
| 2019 Q3 | 1.43 Billion DKK | 7.15% |
| 2019 FY | 5.15 Billion DKK | 1.28% |
| 2019 Q1 | 1.29 Billion DKK | -8.34% |
| 2019 Q2 | 1.34 Billion DKK | 3.47% |
| 2019 Q4 | 1.07 Billion DKK | -24.97% |
| 2018 FY | 5.09 Billion DKK | 1.33% |
| 2018 Q1 | 1.18 Billion DKK | -10.08% |
| 2018 Q4 | 1.41 Billion DKK | 11.51% |
| 2018 Q3 | 1.26 Billion DKK | 5.75% |
| 2018 Q2 | 1.2 Billion DKK | 1.18% |
| 2017 Q4 | 1.31 Billion DKK | 6.97% |
| 2017 Q3 | 1.23 Billion DKK | -1.04% |
| 2017 Q1 | 1.22 Billion DKK | 129.59% |
| 2017 FY | 5.02 Billion DKK | 22.66% |
| 2017 Q2 | 1.24 Billion DKK | 1.63% |
| 2016 FY | 4.09 Billion DKK | 166.84% |
| 2016 Q2 | 1.16 Billion DKK | -2.26% |
| 2016 Q3 | 1.2 Billion DKK | 2.91% |
| 2016 Q1 | 1.19 Billion DKK | 168.19% |
| 2016 Q4 | 534 Million DKK | -55.54% |
| 2015 Q3 | 1.07 Billion DKK | -5.63% |
| 2015 FY | 1.53 Billion DKK | -51.22% |
| 2015 Q1 | 1.07 Billion DKK | -2.18% |
| 2015 Q2 | 1.13 Billion DKK | 5.67% |
| 2015 Q4 | -1.75 Billion DKK | -263.19% |
| 2014 Q1 | 1.01 Billion DKK | 4.11% |
| 2014 Q3 | 1.05 Billion DKK | 6662.5% |
| 2014 FY | 3.14 Billion DKK | -14.3% |
| 2014 Q4 | 1.1 Billion DKK | 4.76% |
| 2014 Q2 | -16 Million DKK | -101.58% |
| 2013 Q1 | 897 Million DKK | 0.67% |
| 2013 FY | 3.67 Billion DKK | 12.81% |
| 2013 Q4 | 973 Million DKK | 3.18% |
| 2013 Q3 | 943 Million DKK | 9.78% |
| 2013 Q2 | 859 Million DKK | -4.24% |
| 2012 Q3 | 901 Million DKK | 17.01% |
| 2012 Q4 | 891 Million DKK | -1.11% |
| 2012 Q2 | 770 Million DKK | 11.11% |
| 2012 FY | 3.25 Billion DKK | 26.11% |
| 2012 Q1 | 693 Million DKK | -6.6% |
| 2011 Q2 | 575 Million DKK | -6.2% |
| 2011 Q1 | 613 Million DKK | 7.54% |
| 2011 FY | 2.58 Billion DKK | 29.37% |
| 2011 Q3 | 651 Million DKK | 13.22% |
| 2011 Q4 | 742 Million DKK | 13.98% |
| 2010 Q1 | 454 Million DKK | 11.82% |
| 2010 FY | 1.99 Billion DKK | 43.01% |
| 2010 Q4 | 570 Million DKK | 9.62% |
| 2010 Q3 | 520 Million DKK | 15.3% |
| 2010 Q2 | 451 Million DKK | -0.66% |
| 2009 Q2 | 308 Million DKK | -7.78% |
| 2009 Q1 | 334 Million DKK | 0.0% |
| 2009 FY | 1.39 Billion DKK | 40.34% |
| 2009 Q4 | 406 Million DKK | 17.0% |
| 2009 Q3 | 347 Million DKK | 12.66% |
| 2008 FY | 994 Million DKK | 32.71% |
| 2007 FY | 749 Million DKK | -14.79% |
| 2006 FY | 879 Million DKK | -12.1% |
| 2005 FY | 1 Billion DKK | 0.28% |
| 2004 FY | 997.17 Million DKK | 7.11% |
| 2003 FY | 931 Million DKK | 1.42% |
| 2002 FY | 918 Million DKK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -628647.144% |
| Ansell Limited | 129.3 Million USD | -5561.253% |
| Ansell Limited | 129.3 Million USD | -5561.253% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -23408.11% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 458832.557% |
| Psykey, Inc. | -797.5 Thousand USD | 917963.735% |
| ConvaTec Group Plc | 262.7 Million USD | -2686.448% |
| ConvaTec Group Plc | 262.7 Million USD | -2686.448% |
| Encision Inc. | -640.78 Thousand USD | 1142452.403% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 5161936.26% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 6658882.862% |
| Innovative MedTech Inc. | -4.27 Million USD | 171365.087% |
| LifePoint, Inc. | -7.49 Million USD | 97762.139% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 113062.963% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -2218081.818% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 5956646.505% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 1566619.288% |
| SmileDirectClub, Inc. | -241.15 Million USD | 3135.38% |
| Sector 10, Inc. | -39.84 Thousand USD | 18371749.433% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -2190.314% |
| SheerVision, Inc. | 155.72 Thousand USD | -4700463.811% |
| United Health Products, Inc. | -2.42 Million USD | 301764.222% |
| Vasamed, Inc. | 4.74 Million USD | -154255.416% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 319173.675% |
| Yubo International Biotech Limited | -1.2 Million USD | 607456.481% |